Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia
Christie Monahan, Lindsey McCoy, Jason Powell, et al.
Annals of Pharmacotherapy (2022) Vol. 56, Iss. 9, pp. 1049-1057
Closed Access | Times Cited: 17

Showing 17 citing articles:

Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Eva-Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 18
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Sulfur- and phosphorus-containing FDA approved drugs in the last five years (2020–2024): A journey among small molecules
Davide Benedetto Tiz, Ornelio Rosati, Luca Sancineto
Phosphorus, sulfur, and silicon and the related elements (2025), pp. 1-39
Open Access
A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)
Luyao He, Mengting Shen, Lei Zhang, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents
George T. Kannarkat, Stanley N. Caroff, James F. Morley
Tremor and Other Hyperkinetic Movements (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
IUPHAR review – Data-driven computational drug repurposing approaches for opioid use disorder
Zhenxiang Gao, Pingjian Ding, Rong Xu
Pharmacological Research (2023) Vol. 199, pp. 106960-106960
Open Access | Times Cited: 6
A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in Schizophrenia
Joseph Dao, Savreen Saran, Melody Wang, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 368-368
Open Access | Times Cited: 4
Quality by design tool evaluated green stability-indicating UPLC content determination method for the Olanzapine and Samidorphan dosage form
Jyothsna Menda, Vaishnavi Chintala, Leela Prasad Kowtharapu, et al.
Microchemical Journal (2023) Vol. 197, pp. 109835-109835
Closed Access | Times Cited: 4
Overview of approved psychiatric medications 2008-2023: A systematic review
Waguih William IsHak, Jayant Totlani, Nathalie Murphy, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 21, Iss. 3, pp. 885-915
Open Access | Times Cited: 1
Precipitated opioid withdrawal in a patient started on olanzapine/samidorphan
Andrew Chambers, J.L. Patton, Brandon K. Wills
The American Journal of Emergency Medicine (2024) Vol. 79, pp. 230.e1-230.e2
Closed Access | Times Cited: 1
A Novel Bioanalytical Method for Simultaneous Determination of Olanzapine and Samidorphan in Human Plasma Using RP-HPLC
Bonagiri Pavani, M. Narender, DSNBK Prasanth, et al.
Indian Journal of Pharmaceutical Education and Research (2023) Vol. 57, Iss. 3, pp. 873-882
Open Access | Times Cited: 3
N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEs of 2021: A Review
Faryal Chaudhry, Rubina Munir, Nayab Malik
Letters in Organic Chemistry (2022) Vol. 20, Iss. 4, pp. 287-299
Closed Access | Times Cited: 5
Olanzapine/samidorphan precipitated opioid withdrawal in a patient taking transdermal fentanyl
Nicholus M. Warstadt, Zachary P. Schmitz, Sari Soghoian
Clinical Toxicology (2022) Vol. 60, Iss. 7, pp. 891-892
Closed Access | Times Cited: 4
Eco-friendly synthesis of new olanzapine derivatives and evaluation of their anticancer potential
Anna K. Drabczyk, Damian Kułaga, Przemysław Zaręba, et al.
RSC Advances (2023) Vol. 13, Iss. 30, pp. 20467-20476
Open Access | Times Cited: 2
Antipsychotic Drugs
Shreedhar Paudel, Carol S. Lim, Oliver Freudenreich
Elsevier eBooks (2024), pp. 555-569
Closed Access
Antipsychotic Drugs
Shreedhar Paudel, Carol S. Lim, Oliver Freudenreich
Elsevier eBooks (2024), pp. 85-99
Closed Access
Acute Metabolic Shifts: Unraveling the Immediate Impacts of Olanzapine on Glucose Metabolism and Glucagon Signaling in Mice
Tushmitha Sundaralingam, Greg C. Smith, Margaret J. Morris, et al.
(2023)
Closed Access
Page 1

Scroll to top